What are the long-term effects of ranolazine on patients with chronic severe angina?
In a 2004 study, Chaitman et al. found that treatment with ranolazine monotherapy had anti-ischemic effects and improved long-term survival in patients with chronic severe angina. Additionally, a 2007 study by Morrow et al. found that ranolazine treatment significantly reduced recurrent cardiovascular events in patients with non-STelevation acute coronary syndromes. Furthermore, a 2008 study by Arnold et al. found that ranolazine treatment had positive effects on disease-specific health status and quality of life among patients with acute coronary syndromes.